Clinical Trial Update: MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma

View source ↗

Summary

Clinical trial update describing a matching-adjusted indirect comparison (MAIC) of Fruquintinib plus paclitaxel versus ramucirumab plus paclitaxel in advanced g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Fruquintinib (fruquintinib)
• PACLITAXEL (PACLITAXEL)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Status: NOT_YET_RECRUITING